Wednesday, October 20

S.Korea secures 20,000 courses of Merck’s COVID-19 pill, says PM


Article content

SEOUL — South Korea has secured 20,000 courses of an experimental antiviral pill developed by Merck & Co for COVID-19 treatment, Prime Minister Kim Boo-kyum said on Wednesday, joining other Asian nations rushing to snap up supplies.

Merck also announced on Wednesday a supply and purchase agreement with Singapore https://www.reuters.com/business/healthcare-pharmaceuticals/merck-says-deal-signed-with-singapore-covid-19-antiviral-pill-2021- 10-06, following Australia https://www.reuters.com/world/asia-pacific/australia-buy-300000-doses-mercks-covid-19-antiviral-pill-2021-10-04, while Thailand https: //www.reuters.com/world/asia-pacific/thailand-talks-with-merck-200000-courses-anti-covid-pills-2021-10-04, Taiwan and Malaysia https://www.reuters.com /business/healthcare-pharmaceuticals/malaysia-talks-procure-mercks-covid-19-pills-2021-10-02 said they are in talks to buy it.

Advertisement

Article content

Molnupiravir, on its way to be the first oral antiviral medication for COVID-19, could halve the chances of dying https://www.reuters.com/business/healthcare-pharmaceuticals/mercks-covid-19-pill-cuts-risk -death-hospitalization-by-50-study-2021-10-01 or being hospitalized for those most at risk of contracting severe COVID-19. Merck is seeking approval by the US Food and Drug Administration for the pill.

The course of treatment involves patients taking four pills twice daily for five days.

“We already have secured a budget enough for treatment of around 40,000 people and have signed a pre-purchase deal for 20,000 courses,” Kim told a COVID-19 response meeting on Wednesday.

South Korea is also looking to buy other antiviral drugs, he said.

Advertisement

Article content

Merck said it plans a tiered pricing approach based on country income criteria. The US government has a contract to buy 1.7 million courses at a price of $700 per course.

The Korea Disease Control and Prevention Agency (KDCA) had said it was also in talks with Pfizer and Swiss drugmaker Roche Holding AG, who are also racing to develop an easy-to-administer antiviral pill https://www.reuters.com/ business/healthcare-pharmaceuticals/covid-19-pill-developers-aim-top-merck-pfizer-efforts-2021-09-28 for COVID-19.

South Korean government had allocated 36.2 billion won ($30.31 million) in budget for oral antiviral pills to cure COVID-19. It has been managing its mortality rate – 0.78% as of Tuesday – and critical cases at a fairly low rate. ($1 = 1,194.2300 won) (Reporting by Sangmi Cha; Editing by Simon Cameron-Moore)

Advertisement

Comments

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.



financialpost.com

Leave a Reply

Your email address will not be published. Required fields are marked *